An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

NCT07236762 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus
Lupus Nephritis (LN)
Sjogren's Syndrome
Inflammatory Myopathy
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Antiphospholipid Syndrome

Interventions

DRUG: YTS109 cell

Sponsor

China Immunotech (Beijing) Biotechnology Co., Ltd.